Literature DB >> 11196515

The psychometric properties of patient preferences in osteoporosis.

A Cranney1, D Coyle, B A Pham, J Tetroe, G Wells, E Jolly, P Tugwell.   

Abstract

OBJECTIVE: Osteoporosis is a chronic disease manifested by wrist, vertebral, and hip fractures that results in significant morbidity and burden to society. About 30% of postmenopausal women have osteoporosis according to the WHO criteria. Women with one vertebral fracture have a 4-fold increased risk of a subsequent fracture. The goal of treatment is to prevent fractures and improve quality of life. Preferences or utilities are now recommended for incorporating quality of life into evaluations of the cost effectiveness of new therapeutic interventions. We evaluated the psychometric properties of preference based measures in osteoporosis.
METHODS: Preference scenarios were constructed with a health state classification system. The reliability and validity of the feeling thermometer and the standard gamble was assessed by interviewing 42 women from 4 different patient groups. The sensitivity to change of the feeling thermometer and standard gamble was compared with the Health Utilities Index Mark 2 (HUI2) and SF-36. All subgroups were reassessed about 2 months after their first interview.
RESULTS: Preference measurement was feasible in women of different age groups. The reliability coefficients for health states ranged from 0.65 to 0.87. The preference scores for the marker states demonstrated content validity. Convergent validity of the feeling thermometer was supported by a significant correlation with the HUI2 (r = 0.38, p < 0.05) and the physical health summary of the SF-36 (r = 0.56, p < 0.005). The standard gamble did not correlate with the HUI2 (r = 0.15) or the feeling thermometer (r = 0.09), but correlated with 2 domains of the SF-36. The preference measures were sensitive to change, with the efficiency scores ranging from 0.78 to 1.0.
CONCLUSION: Preference measurements in the evaluation of osteoporosis are feasible. The feeling thermometer and standard gamble appear to be related to different aspects of health related quality of life. Both instruments were sensitive to change over a 2 month period.

Entities:  

Mesh:

Year:  2001        PMID: 11196515

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  17 in total

1.  The stability of utility scores: test-retest reliability and the interpretation of utility scores in elective total hip arthroplasty.

Authors:  D Feeny; C M Blanchard; J L Mahon; R Bourne; C Rorabeck; L Stitt; S Webster-Bogaert
Journal:  Qual Life Res       Date:  2004-02       Impact factor: 4.147

2.  Acceptability, validity and reliability of the Turkish QUALIOST(®) in postmenopausal women with osteoporosis.

Authors:  Simin Hepguler; Funda Calis Atamaz; Yelda Pinar; Cihat Ozturk
Journal:  Rheumatol Int       Date:  2012-05-15       Impact factor: 2.631

3.  Cost effectiveness of nasal calcitonin in postmenopausal women: use of Cochrane Collaboration methods for meta-analysis within economic evaluation.

Authors:  D Coyle; A Cranney; K M Lee; V Welch; P Tugwell
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

4.  The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective.

Authors:  F Borgström; A Carlsson; H Sintonen; S Boonen; P Haentjens; R Burge; O Johnell; B Jönsson; J A Kanis
Journal:  Osteoporos Int       Date:  2006-03-29       Impact factor: 4.507

5.  Quality-of-life assessment in osteoporosis: health-status and preference-based measures.

Authors:  Anna N A Tosteson; Cristina S Hammond
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 6.  Quality of life in patients with osteoporosis.

Authors:  Paul Lips; Natasja M van Schoor
Journal:  Osteoporos Int       Date:  2004-12-18       Impact factor: 4.507

Review 7.  An updated systematic review of Health State Utility Values for osteoporosis related conditions.

Authors:  T Peasgood; K Herrmann; J A Kanis; J E Brazier
Journal:  Osteoporos Int       Date:  2009-03-07       Impact factor: 4.507

Review 8.  Quality of life in glaucoma and three other chronic diseases: a systematic literature review.

Authors:  Tim Mills; Simon K Law; John Walt; Patricia Buchholz; Jan Hansen
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 9.  Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women.

Authors:  J A Kanis; F Borgstrom; O Johnell; B Jonsson
Journal:  Osteoporos Int       Date:  2004-06-03       Impact factor: 4.507

10.  The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos).

Authors:  J D Adachi; G Ioannidis; L Pickard; C Berger; J C Prior; L Joseph; D A Hanley; W P Olszynski; T M Murray; T Anastassiades; W Hopman; J P Brown; S Kirkland; C Joyce; A Papaioannou; S Poliquin; A Tenenhouse; E A Papadimitropoulos
Journal:  Osteoporos Int       Date:  2003-08-12       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.